Skip to search formSkip to main contentSkip to account menu

Hemocompatibility Testing

Known as: Materials Testing, Hemocompatible, Testings, Hemocompatibility, Hemocompatible Materials Testing 
The testing of BIOCOMPATIBLE MATERIALS, especially those used for EXTRACORPOREAL CIRCULATION; STENTS; or ARTIFICIAL ORGANS, for properties that allow… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Pharmaceutical Potential of a Novel Chitosan Derivative Schiff Base with Special Reference to Antibacterial, Anti-Biofilm, Antioxidant, Anti-Inflammatory, Hemocompatibility and Cytotoxic Activities
Chitosan and its derivatives possess several unique properties relevant in the field of pharmaceutics and medicinal chemistry… 
2017
2017
Strategy for the hemocompatibility testing of microparticles.
Polymer-based microparticles are applied as non-thrombogenic or thrombogenic materials in a wide variety of intra- or extra… 
2016
2016
In vitro hemocompatibility testing: The importance of fresh blood.
The use of unactivated blood for hemocompatibility testing is essential to obtain reliable results. Here, the authors study the… 
2016
2016
In vitro blood flow model with physiological wall shear stress for hemocompatibility testing-An example of coronary stent testing.
Hemocompatibility of blood contacting medical devices has to be evaluated before their intended application. To assess… 
2016
2016
Influence of the blood exposure time in dynamic hemocompatibility testing on coagulation and C5a activation
Within the hemocompatibility testing portfolio of medical devices a range of dynamic models were established in recent years. In… 
2015
2015
In Vitro Hemocompatibility Testing of Dyneema Purity Fibers in Blood Contact
Objective Heart valve and vascular prosthesis implantation is a common procedure for patients with heart valve stenosis or… 
Review
2014
Review
2014
Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity
Hemocompatibility is the goal for any biomaterial contained in extracorporeal life supporting medical devices. The hallmarks for… 
2010
2010
Biopolymer-modified graphite oxide nanocomposite films based on benzalkonium chloride–heparin intercalated in graphite oxide
Heparin is a potent anticoagulant agent that interacts strongly with antithrombin III to prevent the formation of fibrin clots… 
2009
2009
[Considerations on in vitro and in vivo magnetic nanoparticles hemocompatibility testing].
The aim of this paper is to summarize few aspects and underline some difficulties that hemocompatibility testing come up. The… 
Highly Cited
2002
Highly Cited
2002
In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)